Copyright
©The Author(s) 2020.
World J Gastroenterol. Feb 28, 2020; 26(8): 789-803
Published online Feb 28, 2020. doi: 10.3748/wjg.v26.i8.789
Published online Feb 28, 2020. doi: 10.3748/wjg.v26.i8.789
Figure 1 High immune scores and stromal scores are significantly associated with better prognosis in patients with hapetocellular carcinoma.
A: Recurrence-free survival (RFS) between two groups based on immune scores; B: Overall survival (OS) between two groups based on immune scores; C: RFS between two groups based on stromal scores; D: OS between two groups based on stromal scores; E-J: Level of tumor-infiltrating immune cells in the two groups, including B cell, CD4+ T cell, CD8+ T cell, neutrophil, macrophage, and dendritic cell. There were 258 cases with high scores and 86 cases with low scores. aP = 6.9e-15, bP < 2.2e-16, cP = 8.8e-10. RFS: Recurrence-free survival; OS: Overall survival.
- Citation: Pan L, Fang J, Chen MY, Zhai ST, Zhang B, Jiang ZY, Juengpanich S, Wang YF, Cai XJ. Promising key genes associated with tumor microenvironments and prognosis of hepatocellular carcinoma. World J Gastroenterol 2020; 26(8): 789-803
- URL: https://www.wjgnet.com/1007-9327/full/v26/i8/789.htm
- DOI: https://dx.doi.org/10.3748/wjg.v26.i8.789